Lifecore Biomedical, Inc.
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Lifecore Biomedical, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 95 | 1 | 92 | −2 |
| Shares | 25.4M | 1.24M | 25.5M | +1.40M (+5.8%) |
| Value | $285.5M | $13.9M | $235.5M | −$36.1M (−13.3%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Lifecore Biomedical, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Iszo Capital Management LP | 1,648,520 | $15.2M | 6.71% |
| Employees Retirement System of Texas | 85,400 | $787.0K | 0.01% |
| Gsa Capital Partners LLP | 40,153 | $370.0K | 0.04% |
| Algert Global LLC | 31,519 | $291.0K | 0.04% |
| Martingale Asset Management L P | 22,414 | $207.0K | 0.00% |
| Alpine Global Management, LLC | 19,589 | $181.0K | 0.04% |
| Parametric Portfolio Associates LLC | 15,685 | $145.0K | 0.00% |
| Assenagon Asset Management S.A. | 15,651 | $144.0K | 0.00% |
| HSBC Holdings PLC | 13,071 | $121.0K | 0.00% |
| Trexquant Investment LP | 10,750 | $99.0K | 0.01% |
| MetLife Investment Management | 9,994 | $92.1K | 0.00% |
| Metropolitan Life Insurance Co | 7,561 | $69.7K | 0.00% |
| Northwestern Mutual Wealth Management Co | 825 | $8.00K | 0.00% |
| Advisor Group Holdings, Inc. | 334 | $3.00K | 0.00% |
Sold out (16)
Institutions that held Lifecore Biomedical, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Walthausen & Co., LLC | 387,467 | $4.36M |
| SG Capital Management LLC | 144,613 | $1.63M |
| Citadel Advisors LLC | 50,102 | $564.0K |
| Los Angeles Capital Management LLC | 26,520 | $298.0K |
| Susquehanna International Group, LLP | 23,405 | $263.0K |
| Two Sigma Investments, LP | 22,757 | $256.0K |
| Poplar Forest Capital LLC | 18,520 | $208.0K |
| Two Sigma Advisers, LP | 15,464 | $174.0K |
| Engineers Gate Manager LP | 14,926 | $168.0K |
| Jane Street Group, LLC | 14,749 | $166.0K |
| ExodusPoint Capital Management, LP | 12,369 | $139.0K |
| Cubist Systematic Strategies, LLC | 11,580 | $130.0K |
| Panagora Asset Management Inc | 2,112 | $24.0K |
| Point72 Hong Kong Ltd | 808 | $9.00K |
| Geneos Wealth Management Inc. | 675 | $7.00K |
| Signaturefd, LLC | 372 | $4.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Lifecore Biomedical, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Investment Counselors of Maryland LLC | 1,237,620 | $13.9M |